Kai Grass

Partner,

Dusseldorf

Passionate about Healthcare, Corporate M&A and Divestitures with global experience in developed and emerging markets

Kai

専門分野

  • Interlock for M&A in Healthcare & Life Sciences
  • Co-author of Bain's 2023 M&A Report

Kai Grass is a member of our Healthcare & Life Sciences and M&A & Divestitures practices.

Kai’s healthcare work focuses on pharmaceutical and medtech clients. He has extensive experience in biopharma strategy and transformation in different topics such as R&D and clinical trials, M&A, commercial, pricing, and product launch, and emerging markets trends.

His recent client engagements have focused heavily on M&A and Divestiture topics for clients across industries. He is an authority on post-merger integration, carve-out/divestitures and separations, corporate M&A strategy and capability building, as well as value creation plans in post-acquisition situations.

Prior to joining the firm in 2009, he held research roles at Procter & Gamble and various academic institutions.

He holds a Ph.D. in Theoretical Physics from Goethe University, a diploma in physics from the University of Freiburg and a diploma in applied physics from the University of Auckland.

Recent Insights

お気軽にご連絡下さい

私達は、グローバルに活躍する経営者が抱える最重要経営課題に対して、厳しい競争環境の中でも成長し続け、「結果」を出すために支援しています。